{
    "hands_on_practices": [
        {
            "introduction": "The debate over variolation was not just a medical issue; it was a profound question of individual choice under uncertainty. To understand why a rational person might refuse a procedure with a lower average mortality risk, we can use the tools of expected utility theory. This exercise challenges you to apply this economic framework to the historical dilemma, demonstrating how risk aversion can lead individuals to rationally avoid a small, certain cost in favor of preserving a chance at avoiding a larger, though uncertain, catastrophic risk .",
            "id": "4783020",
            "problem": "In the eighteenth century, variolation against smallpox introduced a small, deliberate chance of death in exchange for immunity, while doing nothing left one exposed to a possibly lower chance of encountering smallpox at all but with a higher fatality rate if infected. Let an individual’s lifetime well-being be represented by wealth $w$ and a von Neumann–Morgenstern (VNM) expected utility function $U(w)$ that is strictly increasing and concave, reflecting risk aversion. Death is modeled as $w=0$ with utility $U(0)=0$. Consider the following historically plausible stylized setting to anchor intuition:\n- Baseline wealth $w_0=100$.\n- Variolation imposes a certain cost $c=15$ on survivors and an immediate mortality risk $q=0.015$.\n- Doing nothing leaves a probability $p=0.10$ of contracting smallpox at some point; if infected, the case-fatality risk is $r=0.20$, and survivors of infection incur a morbidity cost $m=50$ (lost productivity, scarring, care costs). With probability $1-p$, the individual is never infected and bears no cost.\nIt is known that expected mortality under variolation, $q$, can be lower than expected mortality under natural exposure, $pr$. In this setup, indeed $q=0.015<pr=0.020$.\n\nUsing only the first principles of VNM expected utility maximization and the definition that concavity of $U$ encodes risk aversion (together with the historically plausible numerical illustration above), which option best explains why a risk-averse individual might rationally oppose variolation even when expected mortality is lower than under natural exposure?\n\nA) Because risk-averse decision-makers maximize expected wealth rather than expected utility, lower expected mortality ($q<pr$) implies lower expected wealth after variolation, so variolation must be worse.\n\nB) Because with concave $U$, the certain loss $c$ imposed on all survivors by variolation and its immediate mortality risk $q$ can reduce expected utility below that of waiting, which preserves a chance $(1-p)$ of no loss at all; formally, it can occur that $(1-q)U(w_0-c)+q\\,U(0)<(1-p)U(w_0)+p\\big[(1-r)U(w_0-m)+r\\,U(0)\\big]$ even when $q<pr$.\n\nC) Because risk-averse individuals always prefer the option with lower variance regardless of costs, variolation is never opposed when its mortality risk is lower.\n\nD) Because concavity of $U$ implies $E[U(W)]=U(E[W])$, only expected wealth matters; hence if expected mortality is lower, variolation must be preferred and cannot be opposed.",
            "solution": "### Step 1: Extract Givens\nThe problem statement provides the following information:\n-   An individual's well-being is represented by wealth, $w$.\n-   The individual has a von Neumann–Morgenstern (VNM) expected utility function, $U(w)$.\n-   The utility function is strictly increasing, $U'(w) > 0$.\n-   The utility function is strictly concave, $U''(w) < 0$, which models risk aversion.\n-   Death corresponds to a wealth level of $w=0$, with an associated utility of $U(0)=0$.\n-   A stylized numerical setting is provided for intuition:\n    -   Baseline wealth, $w_0 = 100$.\n    -   **Variolation option**:\n        -   Certain cost if one survives: $c = 15$.\n        -   Immediate mortality risk: $q = 0.015$.\n    -   **Doing nothing (natural exposure) option**:\n        -   Probability of contracting smallpox: $p = 0.10$.\n        -   Case-fatality risk if infected: $r = 0.20$.\n        -   Morbidity cost if one survives infection: $m = 50$.\n        -   Probability of never being infected: $1-p$.\n-   It is given that the expected mortality under variolation is lower than under natural exposure: $q = 0.015 < pr = (0.10)(0.20) = 0.020$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement must be validated for scientific soundness, clarity, and consistency.\n\n1.  **Scientific Grounding**: The problem is firmly grounded in the principles of expected utility theory, a cornerstone of microeconomic theory and decision theory developed by von Neumann and Morgenstern. The application to the historical medical dilemma of variolation is a classic and appropriate example for illustrating the concepts of risk, risk aversion, and rational choice under uncertainty. The model is a simplification, as acknowledged (\"stylized setting\"), but it is a standard and valid approach for this type of analysis.\n\n2.  **Well-Posedness**: The problem is well-posed. It asks for an explanation of a phenomenon (rational opposition to variolation) within a clearly defined theoretical framework (VNM expected utility) and with a complete set of parameters for a numerical illustration. The question is structured to have a unique conceptual answer derived from the theory.\n\n3.  **Objectivity and Clarity**: The problem is stated using precise, objective, and unambiguous terminology from economics and mathematics (e.g., \"von Neumann–Morgenstern (VNM) expected utility function\", \"strictly increasing and concave\", \"mortality risk\"). There are no subjective or opinion-based claims.\n\n4.  **Consistency**: The data provided are internally consistent. The statement that $q < pr$ is explicitly checked with the given numbers ($0.015 < 0.020$), confirming the premise of the question. All necessary information to construct the expected utility for both choices is provided.\n\nThe problem statement does not violate any of the invalidity criteria. It is scientifically sound, well-posed, objective, internally consistent, and formalizable.\n\n### Step 3: Verdict and Action\nThe problem is valid. I will proceed with the derivation of the solution.\n\n### Solution Derivation\nThe core principle is that a rational individual, according to the VNM framework, chooses the option that maximizes their expected utility. We must formalize the expected utility of the two choices: variolation (V) and doing nothing/natural exposure (N).\n\n**Expected Utility of Variolation ($EU_V$)**\nAn individual who chooses variolation faces a lottery with two outcomes:\n1.  Survival, with probability $(1-q)$: Wealth becomes $w_0 - c$, and utility is $U(w_0 - c)$.\n2.  Death, with probability $q$: Wealth becomes $0$, and utility is $U(0)$.\n\nGiven that $U(0)=0$, the expected utility is:\n$$EU_V = (1-q)U(w_0 - c) + qU(0) = (1-q)U(w_0 - c)$$\n\n**Expected Utility of Doing Nothing ($EU_N$)**\nAn individual who does nothing faces a more complex lottery:\n1.  With probability $(1-p)$, the individual is never infected. Wealth remains $w_0$, and utility is $U(w_0)$.\n2.  With probability $p$, the individual contracts smallpox. This leads to a secondary lottery:\n    a. Survival, with probability $(1-r)$: Wealth becomes $w_0 - m$, and utility is $U(w_0 - m)$.\n    b. Death, with probability $r$: Wealth becomes $0$, and utility is $U(0)$.\n\nThe expected utility of this combined lottery is:\n$$EU_N = (1-p)U(w_0) + p \\left[ (1-r)U(w_0 - m) + rU(0) \\right]$$\nGiven that $U(0)=0$, this simplifies to:\n$$EU_N = (1-p)U(w_0) + p(1-r)U(w_0 - m)$$\n\n**Condition for Opposing Variolation**\nA rational, risk-averse individual would oppose variolation if the expected utility of doing so is lower than the expected utility of doing nothing:\n$$EU_V < EU_N$$\nSubstituting the derived expressions:\n$$(1-q)U(w_0 - c) < (1-p)U(w_0) + p(1-r)U(w_0 - m)$$\nThe question is to explain why this inequality can hold even when $q < pr$. The reason lies in the nature of risk aversion, which is captured by the concavity of $U(w)$. A concave function implies diminishing marginal utility of wealth.\n\nThe variolation option forces a *certain* (if one survives) but relatively small wealth reduction of $c$. The utility of the surviving state is $U(w_0-c)$. The \"doing nothing\" option offers a large probability, $(1-p)$, of the best possible outcome: no loss of wealth and utility $U(w_0)$. This \"upside\" of maintaining full wealth is highly attractive. The downside of natural exposure is a small overall probability, $p$, of a bad outcome, which itself is split between a very bad outcome (death) and a bad outcome (survival with a large cost $m$).\n\nBecause $U(w)$ is concave, the utility loss from the certain cost $c$ in the variolation case, applied to the high-probability survival state, can be significant. Specifically, risk aversion means an individual places a high value on avoiding any loss. The \"doing nothing\" option preserves an $1-p = 0.90$ chance of avoiding any loss whatsoever. The variolation option eliminates this possibility, guaranteeing a loss of at least $c$ in wealth for all $(1-q)=0.985$ of survivors. This trade-off—giving up the high chance of a perfect outcome in exchange for a lower probability of death but a guaranteed smaller cost—can lead a risk-averse person to prefer the \"natural\" lottery.\n\nLet a specific concave function, e.g., $U(w) = \\sqrt{w}$, illustrate this with the given numbers:\n- $w_0=100, c=15, q=0.015$\n- $p=0.10, r=0.20, m=50$\n\n$EU_V = (1-0.015)U(100-15) = 0.985 \\sqrt{85} \\approx 0.985 \\times 9.2195 \\approx 9.081$\n$EU_N = (1-0.10)U(100) + (0.10)(1-0.20)U(100-50) = 0.90\\sqrt{100} + 0.08\\sqrt{50} \\approx 0.90(10) + 0.08(7.071) = 9 + 0.5657 = 9.5657$\n\nSince $9.081 < 9.5657$, a risk-averse individual with this utility function would rationally oppose variolation, even though the mortality risk $q=0.015$ is lower than the natural expected mortality $pr=0.02$.\n\n### Option-by-Option Analysis\n\n**A) Because risk-averse decision-makers maximize expected wealth rather than expected utility, lower expected mortality ($q<pr$) implies lower expected wealth after variolation, so variolation must be worse.**\nThis statement is fundamentally flawed. The definition of a VNM agent, whether risk-averse, risk-neutral, or risk-loving, is that they maximize expected utility. Maximizing expected wealth is the specific behavior of a *risk-neutral* agent (for whom utility is a linear function of wealth). Therefore, the premise \"risk-averse decision-makers maximize expected wealth\" is incorrect. Furthermore, let's calculate the expected wealth for both options.\n$E[W_V] = (1-q)(w_0-c) = (1-0.015)(100-15) = 0.985 \\times 85 = 83.725$.\n$E[W_N] = (1-p)w_0 + p(1-r)(w_0-m) = (0.90)(100) + (0.10)(0.80)(100-50) = 90 + 0.08 \\times 50 = 90+4=94$.\nIn this example, $E[W_V] < E[W_N]$, so a risk-neutral agent would indeed oppose variolation. However, the reason given in the option for why a *risk-averse* person would is based on a false premise about their objective function.\n**Verdict: Incorrect.**\n\n**B) Because with concave $U$, the certain loss $c$ imposed on all survivors by variolation and its immediate mortality risk $q$ can reduce expected utility below that of waiting, which preserves a chance $(1-p)$ of no loss at all; formally, it can occur that $(1-q)U(w_0-c)+q\\,U(0)<(1-p)U(w_0)+p\\big[(1-r)U(w_0-m)+r\\,U(0)\\big]$ even when $q<pr$.**\nThis option correctly identifies all the key elements of the rational choice. It invokes the concavity of $U$ (risk aversion). It correctly contrasts the certain loss $c$ under variolation with the large probability $(1-p)$ of 'no loss at all' under the natural lottery. This is the crucial trade-off. The formal inequality presented is precisely the condition $EU_V < EU_N$ that we derived. Finally, it correctly states that this can occur \"even when $q<pr$,\" which is the central puzzle the question asks to explain. This option is a perfect summary of the logic.\n**Verdict: Correct.**\n\n**C) Because risk-averse individuals always prefer the option with lower variance regardless of costs, variolation is never opposed when its mortality risk is lower.**\nThis statement makes two incorrect claims. First, while risk aversion is related to a dislike of variance, decision-making is not solely based on minimizing variance. A risk-averse individual balances both expected return (or utility) and risk (variance). An option with higher variance but a sufficiently higher expected utility will be preferred. Stating they \"always prefer the option with lower variance regardless of costs\" is false. Second, the conclusion that \"variolation is never opposed when its mortality risk is lower\" is a direct contradiction of the premise of the problem and of the demonstration above. The entire point is to show that it *can* be rationally opposed.\n**Verdict: Incorrect.**\n\n**D) Because concavity of $U$ implies $E[U(W)]=U(E[W])$, only expected wealth matters; hence if expected mortality is lower, variolation must be preferred and cannot be opposed.**\nThis option contains a profound misunderstanding of the mathematics of risk aversion. For a strictly concave function $U$ and a non-constant random variable $W$, Jensen's inequality states that $E[U(W)] < U(E[W])$. The equality $E[U(W)] = U(E[W])$ holds only for linear utility functions (risk neutrality). The premise of the option is therefore mathematically false. Consequently, the conclusion that \"only expected wealth matters\" is also false; it is precisely because $E[U(W)] \\neq U(E[W])$ that expected utility and expected wealth are different criteria and that risk preferences matter. The entire chain of reasoning is built on an incorrect mathematical foundation.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "Moving from individual choice to population-level evidence, a key challenge in the variolation debate was interpreting observational data correctly. Naive comparisons between those who chose variolation and those who did not were often misleading due to 'confounding by indication'—the fact that people at higher risk of infection were more likely to seek the procedure. This practice will guide you through a quantitative demonstration of this bias, allowing you to calculate both the true causal effect and the misleading observational association to see precisely how confounding can understate an intervention's benefits .",
            "id": "4783040",
            "problem": "Eighteenth-century debates over smallpox variolation hinged not only on theology and civic risk but also on whether observed outcomes fairly reflected the causal effect of variolation. Consider a town with $2$ neighborhoods that differ in exposure risk to natural smallpox infection. Let the high-exposure neighborhood be $H$ with probability of exposure $p_H = 0.60$ during the season, and the low-exposure neighborhood be $L$ with probability of exposure $p_L = 0.10$. Let the natural smallpox case fatality rate (CFR) be $m_s = 0.20$. Variolation confers immunity but carries an immediate mortality risk $m_v = 0.015$, independent of neighborhood. Suppose each neighborhood has $N_H = N_L = 10000$ residents. Uptake of variolation differs by neighborhood: in $H$, $80\\%$ of residents choose variolation; in $L$, $10\\%$ choose variolation.\n\nYou are asked to reason only from the definition of expected value and the law of total probability. In particular, use that the expected mortality for an individual with exposure probability $p$ is $p \\cdot m_s$ if not variolated, and $m_v$ if variolated.\n\nTasks:\n- Using only these principles, compute the average causal effect on mortality if variolation were randomly assigned to everyone (i.e., the difference in expected mortality if all were variolated versus if none were variolated), aggregating across neighborhoods by their population shares.\n- Compute the naive, unadjusted difference in observed mortality between those who chose variolation and those who did not, given the stated uptake pattern, by aggregating outcomes within each observed group.\n- Based on your computations and reasoning about independence, answer the multiple-choice question.\n\nMultiple-choice question (select all that apply):\nA. Because higher-exposure individuals are more likely to variolate in this town, the unadjusted difference in observed mortality underestimates the true protective effect of variolation; the dependence between variolation choice and exposure violates the independence condition needed for unbiased naive comparisons.\nB. Provided the variolation mortality risk $m_v$ is constant across neighborhoods, the unadjusted comparison of average mortality between variolated and non-variolated groups consistently estimates the average causal effect, regardless of how people self-select into variolation.\nC. When selection favors higher-exposure individuals choosing variolation, the naive estimate can understate benefits and, in extreme cases, even suggest harm where the intervention is beneficial (a form of Simpson’s paradox driven by exposure confounding).\nD. Independence between the decision to variolate and exposure risk is required for unadjusted comparisons to be unbiased; stratifying by exposure risk or using Inverse Probability Weighting (IPW) to reweight groups by the marginal exposure distribution can recover unbiased estimates under standard assumptions.\nE. Selection into variolation cannot bias expected value comparisons because deaths from variolation occur earlier in time than deaths from natural smallpox, so temporal ordering guarantees that the groups are comparable for causal inference.",
            "solution": "The problem asks us to analyze the causal effect of smallpox variolation versus the observed association in a population with differential uptake and exposure risk. We will first validate the problem statement, then perform the required calculations, and finally evaluate each multiple-choice option.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n-   Neighborhoods: High-exposure ($H$) and Low-exposure ($L$).\n-   Population of neighborhood $H$: $N_H = 10000$.\n-   Population of neighborhood $L$: $N_L = 10000$.\n-   Probability of exposure in $H$: $p_H = 0.60$.\n-   Probability of exposure in $L$: $p_L = 0.10$.\n-   Natural smallpox case fatality rate (CFR): $m_s = 0.20$.\n-   Mortality risk from variolation: $m_v = 0.015$.\n-   Variolation uptake rate in $H$: $v_H = 0.80$ ($80\\%$).\n-   Variolation uptake rate in $L$: $v_L = 0.10$ ($10\\%$).\n-   Expected mortality if not variolated: $p \\cdot m_s$, where $p$ is the exposure probability.\n-   Expected mortality if variolated: $m_v$.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically and mathematically well-defined.\n-   **Scientifically Grounded**: The setup is a simplified but conceptually sound epidemiological model. It reflects a real historical problem—confounding by indication—where those at higher risk are more likely to seek a preventative measure, thus biasing naive observational comparisons. The parameters are hypothetical but lie within a plausible range for such a scenario.\n-   **Well-Posed**: All necessary parameters ($N_H, N_L, p_H, p_L, m_s, m_v, v_H, v_L$) and the calculus for expected mortality are explicitly defined. The tasks are specific and admit a unique solution based on the provided framework.\n-   **Objective**: The problem is stated in precise, quantitative terms, free from ambiguity or subjective language.\n\nThe problem is free of the flaws listed in the instructions. It is not unsound, incomplete, or ill-posed.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. We will proceed with the solution.\n\n### Derivation and Calculations\n\nThe total population is $N = N_H + N_L = 10000 + 10000 = 20000$. The neighborhoods are of equal size, each comprising $50\\%$ of the total population.\n\n**1. Average Causal Effect (ACE) of Variolation**\n\nThe ACE is the difference in expected mortality if everyone were variolated versus if no one were. This is a comparison of two hypothetical scenarios applied to the entire population. Let $Y(1)$ be the mortality outcome if an individual is variolated, and $Y(0)$ if not. The ACE is $E[Y(1)] - E[Y(0)]$.\n\n-   **Expected mortality if all were variolated, $E[Y(1)]$**:\n    If everyone were variolated, each person's mortality risk would be $m_v$. This risk is constant and independent of neighborhood.\n    $$E[Y(1)] = m_v = 0.015$$\n\n-   **Expected mortality if none were variolated, $E[Y(0)]$**:\n    If no one were variolated, mortality would depend on neighborhood-specific exposure risk. We average over the two equally sized neighborhoods.\n    $$E[Y(0)] = \\frac{N_H}{N} \\cdot (p_H \\cdot m_s) + \\frac{N_L}{N} \\cdot (p_L \\cdot m_s)$$\n    $$E[Y(0)] = 0.5 \\cdot (0.60 \\cdot 0.20) + 0.5 \\cdot (0.10 \\cdot 0.20)$$\n    $$E[Y(0)] = 0.5 \\cdot (0.12) + 0.5 \\cdot (0.02) = 0.06 + 0.01 = 0.07$$\n\n-   **Compute the ACE**:\n    $$ACE = E[Y(1)] - E[Y(0)] = 0.015 - 0.07 = -0.055$$\n    The true average causal effect of variolation is a $5.5$ percentage point reduction in mortality.\n\n**2. Naive, Unadjusted Difference in Observed Mortality**\n\nThis is the difference in average mortality between the group of people who actually chose variolation and the group who did not. Let $V=1$ denote choosing variolation and $V=0$ denote not choosing it. We compute $E[Y|V=1] - E[Y|V=0]$.\n\n-   **Analyze the Variolated Group ($V=1$):**\n    -   Number of variolated people from $H$: $N_{H,v} = N_H \\cdot v_H = 10000 \\cdot 0.80 = 8000$.\n    -   Number of variolated people from $L$: $N_{L,v} = N_L \\cdot v_L = 10000 \\cdot 0.10 = 1000$.\n    -   Total number of variolated people: $N_v = 8000 + 1000 = 9000$.\n    -   The mortality for any person in this group is $m_v = 0.015$.\n    -   Observed mortality in the variolated group: $E[Y|V=1] = m_v = 0.015$.\n\n-   **Analyze the Non-Variolated Group ($V=0$):**\n    -   Number of non-variolated people from $H$: $N_{H,nv} = N_H \\cdot (1-v_H) = 10000 \\cdot 0.20 = 2000$.\n    -   Number of non-variolated people from $L$: $N_{L,nv} = N_L \\cdot (1-v_L) = 10000 \\cdot 0.90 = 9000$.\n    -   Total number of non-variolated people: $N_{nv} = 2000 + 9000 = 11000$.\n    -   The mortality in this group is a weighted average of the mortality rates for non-variolated individuals in each neighborhood, with weights given by the composition of this group.\n    -   Mortality for a non-variolated person in $H$: $p_H \\cdot m_s = 0.12$.\n    -   Mortality for a non-variolated person in $L$: $p_L \\cdot m_s = 0.02$.\n    -   Observed mortality in the non-variolated group:\n        $$E[Y|V=0] = \\frac{N_{H,nv}}{N_{nv}} \\cdot (p_H \\cdot m_s) + \\frac{N_{L,nv}}{N_{nv}} \\cdot (p_L \\cdot m_s)$$\n        $$E[Y|V=0] = \\frac{2000}{11000} \\cdot (0.12) + \\frac{9000}{11000} \\cdot (0.02)$$\n        $$E[Y|V=0] = \\frac{2}{11} \\cdot 0.12 + \\frac{9}{11} \\cdot 0.02 = \\frac{0.24 + 0.18}{11} = \\frac{0.42}{11} \\approx 0.03818$$\n\n-   **Compute the Naive Difference**:\n    $$\\text{Naive Difference} = E[Y|V=1] - E[Y|V=0] = 0.015 - \\frac{0.42}{11} \\approx 0.015 - 0.03818 = -0.02318$$\n    The naive, unadjusted comparison suggests a $2.3$ percentage point reduction in mortality.\n\n**Comparison of Results**\nThe magnitude of the true protective effect is $|-0.055| = 0.055$.\nThe magnitude of the naive observed protective effect is $|-0.02318| \\approx 0.023$.\nSince $0.023 < 0.055$, the naive comparison substantially *underestimates* the true benefit of variolation. This is because the \"control\" group (non-variolated) is disproportionately composed of low-risk individuals (from neighborhood $L$), making it seem healthier than a true control group would be.\n\n### Option-by-Option Analysis\n\n**A. Because higher-exposure individuals are more likely to variolate in this town, the unadjusted difference in observed mortality underestimates the true protective effect of variolation; the dependence between variolation choice and exposure violates the independence condition needed for unbiased naive comparisons.**\nThis statement is fully supported by our calculations. The uptake of variolation is $80\\%$ in the high-exposure neighborhood ($H$) versus $10\\%$ in the low-exposure one ($L$), so higher-exposure individuals are indeed more likely to variolate. Our calculation showed the unadjusted protective effect ($2.3\\%$ reduction) is much smaller than the true causal protective effect ($5.5\\%$ reduction), meaning it underestimates the benefit. This bias arises precisely because the choice to variolate is dependent on exposure risk, violating the independence assumption required for a naive comparison to be causally valid.\n**Verdict: Correct**\n\n**B. Provided the variolation mortality risk $m_v$ is constant across neighborhoods, the unadjusted comparison of average mortality between variolated and non-variolated groups consistently estimates the average causal effect, regardless of how people self-select into variolation.**\nThis is incorrect. The core of the problem is confounding due to self-selection (also called selection bias or confounding by indication). The fact that $m_v$ is constant does not resolve the issue that the non-variolated group is not a valid counterfactual for the variolated group. Our calculations explicitly show that the unadjusted comparison ($-0.023$) is not equal to the average causal effect ($-0.055$), demonstrating the presence of bias caused by self-selection.\n**Verdict: Incorrect**\n\n**C. When selection favors higher-exposure individuals choosing variolation, the naive estimate can understate benefits and, in extreme cases, even suggest harm where the intervention is beneficial (a form of Simpson’s paradox driven by exposure confounding).**\nOur calculation directly shows that the naive estimate understates the benefit. The second part of the statement, about suggesting harm, is a known feature of this type of confounding. If the baseline risk in the variolated group is sufficiently high compared to the baseline risk in the non-variolated group, the raw comparison can be misleading. While our specific numbers do not show a sign reversal (i.e., suggest harm), it is a conceptually correct extension. For variolation to be deemed harmful, we would need $E[Y|V=1] > E[Y|V=0]$, or $0.015 > E[Y|V=0]$. Since the minimum mortality in the non-variolated group is $p_L m_s = 0.02$, this cannot happen with the given parameters. However, the statement is a general principle about this confounding structure, and is a valid generalization of the observed understatement of benefit. This is a classic illustration of Simpson's paradox.\n**Verdict: Correct**\n\n**D. Independence between the decision to variolate and exposure risk is required for unadjusted comparisons to be unbiased; stratifying by exposure risk or using Inverse Probability Weighting (IPW) to reweight groups by the marginal exposure distribution can recover unbiased estimates under standard assumptions.**\nThis is a correct statement from the field of causal inference. The first clause identifies the core assumption of \"no confounding\" (independence). The second clause lists two standard statistical techniques—stratification and IPW—used to control for confounding variables like exposure risk. As demonstrated in thought, stratifying by neighborhood (our proxy for risk) and averaging a weighted sum of the stratum-specific causal effects correctly recovers the ACE of $-0.055$. IPW is another valid technique for the same purpose.\n**Verdict: Correct**\n\n**E. Selection into variolation cannot bias expected value comparisons because deaths from variolation occur earlier in time than deaths from natural smallpox, so temporal ordering guarantees that the groups are comparable for causal inference.**\nThis statement is logically flawed. The bias in the comparison arises from pre-existing differences in risk between the groups that choose variolation and those that do not. The timing of when deaths occur (immediately from variolation vs. later from natural infection) has no bearing on correcting for this initial selection bias. The groups arefundamentally not comparable in their baseline risk profile, and temporal ordering of outcomes does not magically make them so.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{ACD}$$"
        },
        {
            "introduction": "Having identified the pitfalls of individual risk perception and observational data, the ultimate question becomes: how could one have generated more definitive evidence in the 18th century? This final exercise challenges you to step into the role of a pioneering public health investigator and evaluate potential study designs. By weighing the strengths and weaknesses of different approaches against the ethical and logistical constraints of 1721 Boston, you will develop a deeper appreciation for how robust causal inference is achieved in practice .",
            "id": "4783059",
            "problem": "In the smallpox outbreak of $1721$ in Boston, physicians and clergy debated the safety and efficacy of variolation (the deliberate introduction of smallpox matter to induce a milder disease and subsequent immunity). Contemporary observational comparisons suffered from severe confounding by indication: the decision to undergo variolation depended on prior beliefs, perceived exposure risk, social status, and access to practitioners, so that $P(Y \\mid A=1) - P(Y \\mid A=0)$ did not identify the causal effect, where $A$ denotes receipt of variolation and $Y$ denotes an outcome such as smallpox mortality. From first principles of causal inference, unbiased estimation of a causal effect requires exchangeability, which can be achieved in expectation by random assignment, and ethical defensibility requires some form of consent or social legitimacy in conditions of uncertainty (equipoise). In $1721$ Boston, the following resources and constraints were plausible: parish and town records, notaries, the capacity to quarantine households, lotteries recognized as fair procedures by civic and church authorities, and the absence of modern germ theory or laboratory assays. Consider designs that do not deliberately expose unimmunized people to smallpox beyond the prevailing epidemic risk, avoid coercion, and rely on procedures that could reasonably have been organized by local magistrates, ministers, and physicians.\n\nWhich one of the following trial designs would most strengthen causal inference about the effect of variolation on smallpox outcomes while remaining feasible and ethically plausible for $1721$ Boston?\n\nA. Among households that declare willingness to be variolated, conduct a stepped-wedge cluster-randomized rollout: randomize consenting households within each parish by lottery to receive variolation at different preassigned dates over the ensuing weeks, maintain standard quarantine after variolation, and use parish records to pre-register outcomes (smallpox incidence, severity, and mortality). Analyze differences between early and late clusters at each time step with a prespecified difference-in-means estimator, controlling for calendar time.\n\nB. Conduct a matched case–control study after the epidemic using church burial registers to identify smallpox deaths, matching each decedent to two parishioners of similar age and neighborhood who survived, and ascertain prior variolation status from ministerial notes and physician ledgers.\n\nC. Assign variolation by alternation along streets on a single day (every other household offered variolation regardless of consent), thereby ensuring near-equal numbers of variolated and non-variolated households distributed across the town at the outset of the epidemic.\n\nD. Perform a human challenge study: variolate a group of volunteers and, after recovery, expose both variolated and non-variolated volunteers to the effluvia of smallpox patients under controlled observation to directly compare attack rates.\n\nE. Implement a randomized encouragement design: by lot, select certain parishes to receive sermons and public notices endorsing variolation, while others receive neutral messages; measure uptake and subsequent smallpox outcomes, and estimate the causal effect using the randomized encouragement as an instrument for variolation.",
            "solution": "## Problem Validation\n\n### Step 1: Extract Givens\nThe problem statement provides the following information:\n1.  **Context**: Smallpox outbreak in Boston, $1721$.\n2.  **Intervention**: Variolation, the deliberate introduction of smallpox matter.\n3.  **Outcome**: Smallpox outcomes, such as incidence, severity, and mortality ($Y$).\n4.  **Causal Question**: The effect of variolation ($A$) on the outcome ($Y$).\n5.  **Identified Problem**: Observational comparisons, such as the risk difference $P(Y \\mid A=1) - P(Y \\mid A=0)$, are biased due to confounding by indication.\n6.  **Causal Inference Principles**:\n    *   Unbiased estimation requires exchangeability.\n    *   Random assignment achieves exchangeability in expectation.\n    *   Ethical defensibility requires consent or social legitimacy under uncertainty (equipoise).\n7.  **Plausible Resources & Constraints (1721 Boston)**:\n    *   Parish and town records.\n    *   Notaries.\n    *   Capacity to quarantine households.\n    *   Lotteries recognized as fair procedures.\n    *   Absence of modern germ theory or laboratory assays.\n8.  **Required Design Characteristics**:\n    *   Must not deliberately expose unimmunized people to smallpox beyond the prevailing epidemic risk.\n    *   Must avoid coercion.\n    *   Must rely on procedures organizable by local authorities.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated against the validation criteria.\n\n*   **Scientifically Grounded**: Yes. The problem is historically accurate, referencing the $1721$ Boston smallpox epidemic and the debates surrounding Zabdiel Boylston and Cotton Mather's advocacy for variolation. The epidemiological concepts presented—confounding by indication, exchangeability, and randomization as a solution—are fundamental principles of causal inference. The expression $P(Y \\mid A=1) - P(Y \\mid A=0)$ correctly represents the associational difference, which may not equal the causal effect.\n*   **Well-Posed**: Yes. The question is clear and specific, asking for the identification of the *best* study design among a given set of options, evaluated against explicit criteria: strengthening causal inference, historical feasibility, and ethical plausibility.\n*   **Objective**: Yes. The language is neutral, formal, and free of subjective claims. It presents historical facts and scientific principles without bias.\n\nThe problem does not exhibit any of the listed flaws:\n1.  **Scientific or Factual Unsoundness**: The premises are sound.\n2.  **Non-Formalizable or Irrelevant**: The topic is a classic case study in the history of epidemiology and is highly formalizable.\n3.  **Incomplete or Contradictory Setup**: The setup is detailed and self-consistent, providing sufficient context and constraints to evaluate the options.\n4.  **Unrealistic or Infeasible**: The problem is carefully framed to work within realistic historical and scientific constraints.\n5.  **Ill-Posed or Poorly Structured**: The question is well-defined.\n6.  **Pseudo-Profound, Trivial, or Tautological**: The problem is non-trivial, requiring a nuanced understanding of study design, ethics, and historical context.\n7.  **Outside Scientific Verifiability**: The merits of different epidemiological study designs are a verifiable topic within the science of public health and statistics.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. The analysis will proceed to the solution.\n\n## Solution Derivation\n\nThe core task is to identify the study design that best satisfies three criteria: (1) strength of causal inference, (2) feasibility in $1721$ Boston, and (3) ethical plausibility for the time. The strongest causal inference is typically achieved through randomization, which creates exchangeable groups (in expectation) and thus minimizes confounding.\n\n### Option-by-Option Analysis\n\n**A. Among households that declare willingness to be variolated, conduct a stepped-wedge cluster-randomized rollout: randomize consenting households within each parish by lottery to receive variolation at different preassigned dates over the ensuing weeks, maintain standard quarantine after variolation, and use parish records to pre-register outcomes (smallpox incidence, severity, and mortality). Analyze differences between early and late clusters at each time step with a prespecified difference-in-means estimator, controlling for calendar time.**\n\n*   **Causal Inference**: This design is exceptionally strong. It employs **randomization** (via lottery) to determine the *timing* of the intervention. At any point before the final step, the \"early\" clusters (already variolated) can be compared to the \"late\" clusters (not yet variolated). Because the assignment of timing is random, these two groups are exchangeable, aside from the intervention itself and the passage of a small amount of calendar time (which the design proposes to control for). This directly breaks the confounding by indication that plagues observational studies. Pre-registration of outcomes prevents reporting bias.\n*   **Feasibility**: This design is highly feasible given the stated resources. It uses lotteries, which were recognized as fair. It operates at the household level (\"clusters\") and uses parish records. The sequential rollout is logistically practical during a unfolding epidemic.\n*   **Ethics**: This design is ethically plausible. It operates only on \"households that declare willingness,\" thus respecting consent and avoiding coercion. A randomized rollout is an established ethical method for allocating a potentially beneficial but risky intervention when it cannot be given to all eligible and willing parties simultaneously. It does not deny variolation to anyone who wants it, but fairly allocates the order. It does not expose anyone to risk beyond the ongoing epidemic.\n*   **Verdict**: **Correct**. This design robustly addresses the challenges of causal inference, feasibility, and ethics.\n\n**B. Conduct a matched case–control study after the epidemic using church burial registers to identify smallpox deaths, matching each decedent to two parishioners of similar age and neighborhood who survived, and ascertain prior variolation status from ministerial notes and physician ledgers.**\n\n*   **Causal Inference**: This is a retrospective **observational** study design. While matching on age and neighborhood attempts to control for some confounding variables, it cannot control for unmeasured or unrecorded confounders, which are the essence of \"confounding by indication\" (e.g., pre-existing health status, wealth, belief in medicine, exact exposure risk). It is a significant improvement over a crude, unmatched comparison, but it is fundamentally inferior to a randomized experiment for establishing causality.\n*   **Feasibility**: This is feasible, using the church registers and other records mentioned.\n*   **Ethics**: As a retrospective study, it poses minimal ethical risk to subjects, mainly concerning the use of their data.\n*   **Verdict**: **Incorrect**. This design is weaker for causal inference than a randomized design.\n\n**C. Assign variolation by alternation along streets on a single day (every other household offered variolation regardless of consent), thereby ensuring near-equal numbers of variolated and non-variolated households distributed across the town at the outset of the epidemic.**\n\n*   **Causal Inference**: This is a quasi-experimental design. The \"alternation\" assignment is systematic, not truly random, and could correlate with unobserved factors. However, the most significant flaw is ethical.\n*   **Feasibility**: Logistically simple.\n*   **Ethics**: The phrase \"regardless of consent\" is a fatal flaw. It explicitly violates the stated constraint to \"avoid coercion.\" Forcing a risky medical procedure on unwilling individuals is ethically unacceptable, both by modern standards and by the plausible standards of a community that included vigorous public debate on the matter.\n*   **Verdict**: **Incorrect**. The design is ethically indefensible due to its coercive nature.\n\n**D. Perform a human challenge study: variolate a group of volunteers and, after recovery, expose both variolated and non-variolated volunteers to the effluvia of smallpox patients under controlled observation to directly compare attack rates.**\n\n*   **Causal Inference**: This design would yield very strong evidence regarding the efficacy of variolation in preventing infection upon direct exposure.\n*   **Feasibility**: The \"controlled observation\" might be feasible in a pest house.\n*   **Ethics**: This is a grave ethical violation. It directly contradicts the explicit constraint to \"not deliberately expose unimmunized people to smallpox beyond the prevailing epidemic risk.\" A human challenge study *intentionally infects* the control group with a deadly pathogen. This poses an unacceptable risk of severe harm and death to the control subjects with no prospect of direct benefit.\n*   **Verdict**: **Incorrect**. The design is ethically impossible and violates a key rule of the problem.\n\n**E. Implement a randomized encouragement design: by lot, select certain parishes to receive sermons and public notices endorsing variolation, while others receive neutral messages; measure uptake and subsequent smallpox outcomes, and estimate the causal effect using the randomized encouragement as an instrument for variolation.**\n\n*   **Causal Inference**: This is a valid and sophisticated randomized design, using an Instrumental Variable (IV) approach. Randomizing encouragement creates exchangeable groups at the parish level with respect to their *propensity to be encouraged*. It is a powerful method for dealing with non-compliance. However, it estimates the \"complier average causal effect\" (CACE)—the effect of variolation on the subpopulation of people who would only get variolated if encouraged. This estimand may differ from the effect on other groups, and the statistical power of the design depends on how strongly the encouragement influences uptake.\n*   **Feasibility**: Entirely feasible using the means of communication and a lottery system as described.\n*   **Ethics**: Ethically sound. It does not coerce anyone and respects individual choice.\n*   **Comparison to A**: While Design E is valid, Design A is arguably superior in this context. The stepped-wedge design (A) randomizes the actual intervention (or its timing) among all willing participants, allowing for a more direct estimation of the average effect in this population. It is generally more statistically efficient and provides a more direct answer to the question of variolation's effect, compared to the more specific CACE estimand from the IV approach. Therefore, Design A would \"most strengthen\" causal inference in a more direct manner.\n*   **Verdict**: **Incorrect**. While a strong design, it is arguably less direct and potentially less powerful than the stepped-wedge design (A) for answering the primary public health question.\n\n### Conclusion\nOption A presents a stepped-wedge cluster-randomized trial, which is a state-of-the-art design. It masterfully threads the needle, achieving strong causal inference through randomization while remaining entirely within the ethical and logistical constraints of $1721$ Boston. It is superior to the observational design (B), the coercive design (C), the unethical challenge study (D), and the less direct instrumental variable design (E).",
            "answer": "$$\\boxed{A}$$"
        }
    ]
}